|
O'Dwyer, P J; Moyer, J D; Suffness, M et al. (1994) Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. Cancer Res 54:724-9
|
|
Zaharko, D; Plowman, J; Waud, W et al. (1992) L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice. Cancer Res 52:3604-9
|
|
Harrison Jr, S D; Plowman, J; Dykes, D J et al. (1991) Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brain. Cancer Res 51:1979-83
|
|
Harrison Jr, S D; Plowman, J; Dykes, D J et al. (1990) Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo. Cancer Chemother Pharmacol 25:425-9
|
|
Plowman, J; Harrison, S D; Dykes Jr, D J et al. (1989) Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumors. Cancer Res 49:1909-15
|
